Humana Inc (NYSE:HUM) Forecasted to Post FY2019 Earnings of $17.78 Per Share

Humana Inc (NYSE:HUM) – Equities research analysts at SunTrust Banks upped their FY2019 earnings estimates for Humana in a report issued on Wednesday, November 6th. SunTrust Banks analyst D. Macdonald now expects that the insurance provider will post earnings per share of $17.78 for the year, up from their previous estimate of $17.64. SunTrust Banks currently has a “Hold” rating and a $335.00 target price on the stock. SunTrust Banks also issued estimates for Humana’s Q4 2019 earnings at $2.22 EPS, Q1 2020 earnings at $4.80 EPS, Q2 2020 earnings at $5.94 EPS, Q3 2020 earnings at $5.04 EPS, Q4 2020 earnings at $2.86 EPS and FY2020 earnings at $18.64 EPS.

Several other equities analysts have also recently issued reports on HUM. BMO Capital Markets cut shares of Humana from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $345.00 to $290.00 in a research report on Monday, September 30th. Piper Jaffray Companies boosted their target price on shares of Humana from $315.00 to $341.00 and gave the company an “overweight” rating in a report on Thursday, August 1st. ValuEngine upgraded shares of Humana from a “hold” rating to a “buy” rating in a report on Friday. Morgan Stanley dropped their price target on shares of Humana from $342.00 to $337.00 and set an “overweight” rating on the stock in a research note on Thursday, September 26th. Finally, Deutsche Bank started coverage on shares of Humana in a research note on Thursday, September 12th. They issued a “hold” rating and a $300.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and seventeen have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $335.45.

NYSE HUM traded up $1.08 on Friday, hitting $316.22. The company’s stock had a trading volume of 33,296 shares, compared to its average volume of 901,090. The company has a quick ratio of 1.75, a current ratio of 1.75 and a debt-to-equity ratio of 0.37. Humana has a 1-year low of $225.65 and a 1-year high of $353.05. The company’s 50-day moving average is $276.72 and its 200 day moving average is $270.55. The firm has a market cap of $39.82 billion, a PE ratio of 21.74, a PEG ratio of 1.27 and a beta of 0.85.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 6th. The insurance provider reported $5.03 EPS for the quarter, beating the consensus estimate of $4.58 by $0.45. The business had revenue of $16.24 billion for the quarter, compared to analysts’ expectations of $16.15 billion. Humana had a net margin of 4.13% and a return on equity of 22.47%. The firm’s revenue was up 14.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.58 EPS.

Hedge funds have recently added to or reduced their stakes in the business. Maverick Capital Ltd. lifted its stake in shares of Humana by 150.9% in the second quarter. Maverick Capital Ltd. now owns 1,550,726 shares of the insurance provider’s stock worth $411,408,000 after acquiring an additional 932,778 shares in the last quarter. Wells Fargo & Company MN lifted its stake in shares of Humana by 1.8% in the second quarter. Wells Fargo & Company MN now owns 1,367,476 shares of the insurance provider’s stock valued at $362,790,000 after buying an additional 24,314 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in shares of Humana by 1.8% in the second quarter. Bank of New York Mellon Corp now owns 1,181,373 shares of the insurance provider’s stock valued at $313,417,000 after buying an additional 21,207 shares in the last quarter. Amundi Pioneer Asset Management Inc. lifted its stake in shares of Humana by 76.7% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 877,582 shares of the insurance provider’s stock valued at $232,822,000 after buying an additional 380,979 shares in the last quarter. Finally, California Public Employees Retirement System lifted its stake in shares of Humana by 8.6% in the third quarter. California Public Employees Retirement System now owns 850,334 shares of the insurance provider’s stock valued at $217,405,000 after buying an additional 67,252 shares in the last quarter. Institutional investors and hedge funds own 92.93% of the company’s stock.

In other Humana news, insider Brian P. Leclaire sold 7,239 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $289.70, for a total value of $2,097,138.30. Following the sale, the insider now owns 12,994 shares in the company, valued at $3,764,361.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.54% of the company’s stock.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend is Monday, December 30th. Humana’s dividend payout ratio (DPR) is currently 15.12%.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Story: The components of the Stochastic Momentum Index

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply